Literature DB >> 32663879

Image-enhanced endoscopy for gastric preneoplastic conditions and neoplastic lesions: a systematic review and meta-analysis.

Marta Rodríguez-Carrasco1, Gianluca Esposito2, Diogo Libânio1,3, Pedro Pimentel-Nunes1,3,4, Mário Dinis-Ribeiro1,3.   

Abstract

BACKGROUND : Image-enhanced endoscopy (IEE) improves the accuracy of endoscopic diagnosis. We aimed to assess the value of IEE for gastric preneoplastic conditions and neoplastic lesions. METHODS : Medline and Embase were searched until December 2018. Studies allowing calculation of diagnostic measures were included. Risk of bias and applicability were assessed using QUADAS-2. Subgroup analysis was performed to explore heterogeneity. RESULTS : 44 studies met the inclusion criteria. For gastric intestinal metaplasia (GIM), narrow-band imaging (NBI) obtained a pooled sensitivity and specificity of 0.79 (95 %CI 0.72-0.85) and 0.91 (95 %CI 0.88-0.94) on per-patient basis; on per-biopsy basis, it was 0.84 (95 %CI 0.81-0.86) and 0.95 (95 %CI 0.94-0.96), respectively. Tubulovillous pattern was the most accurate marker to detect GIM and it was effectively assessed without high magnification. For dysplasia, NBI showed a pooled sensitivity and specificity of 0.87 (95 %CI 0.84-0.89) and 0.97 (95 %CI 0.97-0.98) on per-biopsy basis. The use of magnification improved the performance of NBI to characterize early gastric cancer (EGC), especially when the vessel plus surface (VS) classification was applied. Regarding other technologies, trimodal imaging also obtained a high accuracy for dysplasia (sensitivity 0.93 [95 %CI 0.85-0.98], specificity 0.98 [95 %CI 0.92-1.00]). For atrophic gastritis, no specific pattern was noted and none of the technologies reached good diagnostic yield. CONCLUSION : NBI is highly accurate for GIM and dysplasia. The presence of tubulovillous pattern and the VS classification seem to be useful to detect GIM and characterize EGC, respectively. These features should be used in current practice and to standardize endoscopic criteria for other technologies. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32663879     DOI: 10.1055/a-1205-0570

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  5 in total

Review 1.  AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.

Authors:  Shailja C Shah; M Blanca Piazuelo; Ernst J Kuipers; Dan Li
Journal:  Gastroenterology       Date:  2021-08-26       Impact factor: 33.883

2.  Gastric intestinal metaplasia: can we abandon random biopsies.

Authors:  Gianluca Esposito; Mário Dinis-Ribeiro
Journal:  Endosc Int Open       Date:  2022-04-14

3.  Endoscopic diagnosis of gastric intestinal metaplasia in patients with autoimmune gastritis using narrow-band imaging: does pseudopyloric metaplasia muddy the waters?

Authors:  Emanuele Dilaghi; Gianluca Esposito; Giulia Pivetta; Gloria Galli; Emanuela Pilozzi; Bruno Annibale; Edith Lahner
Journal:  Endosc Int Open       Date:  2022-04-14

Review 4.  Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency.

Authors:  Gianluca Esposito; Ludovica Dottori; Giulia Pivetta; Irene Ligato; Emanuele Dilaghi; Edith Lahner
Journal:  Nutrients       Date:  2022-04-17       Impact factor: 6.706

5.  Risk of progression in patients with chronic atrophic gastritis: A retrospective study.

Authors:  Lu Sun; Xiaoliang Jin; Liang Huang; Jing Zhao; Haifeng Jin; Mingtao Chen; Chunli Zhang; Bin Lu
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.